BIO-RAD LABORATORIES, INC. (BIO-B) Stock Forecast

Bio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call Transcript

1y ago, source: Seeking Alpha

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q2 2024 Earnings Conference Call August 1, 2024 5:00 PM ETCompany ParticipantsEdward Chung - Vice President of ...

Bio-Rad Laboratories, Inc. (NYSE:BIO) Stock Is Going Strong But ...

16d ago, source: Yahoo Finance

Bio-Rad Laboratories' (NYSE:BIO) stock is up by a considerable 20% over the past three months. However, we decided to pay attention to the company's fundamentals which don't appear to give a clear ...

Should You be Optimistic on Bio-Rad Laboratories’s (BIO) Outlook?

3mon ago, source: Yahoo Finance

On April 17, 2025, Bio-Rad Laboratories, Inc. (NYSE:BIO) stock closed at $238.18 per share with a market capitalization of $6.691 billion.

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

20y ago, source: U.S. News & World Report

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications.

Bio-Rad Laboratories, Inc. (NYSE:BIO) insiders may have ... - Nasdaq

3y ago, source: Nasdaq

Despite the fact that Bio-Rad Laboratories, Inc.'s (NYSE:BIO) value has dropped 4.8% in the last week insiders who sold US$2.2m worth of stock in the past 12 months have had less success. Given ...

Credit Suisse Maintains Bio-Rad Laboratories Inc. - (BIO ... - Nasdaq

2y ago, source: Nasdaq

As of August 2, 2023, the average one-year price target for Bio-Rad Laboratories Inc. - is 559.64. The forecasts range from a low of 515.10 to a high of $635.25.

Bio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ ...

1y ago, source: Insider Monkey

We recently compiled a list of the 10 Best Organ Transplant and Diagnosis Stocks To Buy Now. In this article, we are going to take a look at where Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories is Now Oversold (BIO) - Forbes

10y ago, source: Forbes

In trading on Wednesday, shares of Bio-Rad Laboratories, Inc. (NYSE: BIO) entered into oversold territory, hitting an RSI reading of 28.5, after changing hands as low as $114.17 per share.

Bio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call Transcript

9mon ago, source: Seeking Alpha

Bio-Rad Laboratories, Inc. (NYSE: BIO) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Edward Chung - Vice President of Investor Relations Norman Schwartz ...

Company	Ticker	90 Days Forecast	Market Cap. (USD M)	P/E	P/B
AGILENT TECHNOLOGIES, INC.	A	Predict	34091.20	29.24	5.56
Akoya Biosciences, Inc.	AKYA	Predict	64.34	-2.14	-10.93
ASTROTECH Corp	ASTC	Predict	8.52	28.87	0.34
Avantor, Inc.	AVTR	Predict	8818.26	12.83	1.40
Accelerate Diagnostics, Inc	AXDX	Predict	0.18	-0.21	0.00
BIO-RAD LABORATORIES, INC.	BIO	Predict	7856.93	24.62	1.10
BIO-RAD LABORATORIES, INC.	BIO-B	Predict	6815.86	21.36	0.96
Bionano Genomics, Inc.	BNGO	Predict	11.88	-0.04	0.26
BRUKER CORP	BRKR	Predict	6144.61	28.33	3.18
Cytek Biosciences, Inc.	CTKB	Predict	511.81	82.00	1.36
EyePoint Pharmaceuticals, Inc.	EYPT	Predict	763.99	-4.43	3.11
HARVARD BIOSCIENCE INC	HBIO	Predict	23.60	-8.33	1.50
ILLUMINA, INC.	ILMN	Predict	15817.38	12.58	7.00
STANDARD BIOTOOLS INC.	LAB	Predict	469.48	-2.36	1.11
Lifeloc Technologies, Inc	LCTC	Predict	8.95	None	1.52
METTLER TOLEDO INTERNATIONAL INC/	MTD	Predict	24912.94	31.51	-136.90
Nautilus Biotechnology, Inc.	NAUT	Predict	90.06	-3.78	0.50
Singular Genomics Systems, Inc.	OMIC	Predict	50.26	-1.71	0.41
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.	PACB	Predict	393.46	-1.52	6.40
Precipio, Inc.	PRPO	Predict	21.94	-1.15	0.62
Quanterix Corp	QTRX	Predict	208.51	-11.12	0.66
RAPID MICRO BIOSYSTEMS, INC.	RPID	Predict	116.12	-0.87	2.13
REVVITY, INC.	RVTY	Predict	10792.11	37.84	1.43
Seer, Inc.	SEER	Predict	131.32	-1.95	0.38
10x Genomics, Inc.	TXG	Predict	1660.09	-8.57	2.15
WATERS CORP /DE/	WAT	Predict	17401.45	26.31	8.06